Complement inhibition by soluble complement receptor type 1 fails to moderate cerulein-induced pancreatitis in the rat

International Journal of Pancreatology

Volumn 19, Issue 2, 1996, Pages 129-134

  Weiser, Martin R ^b   Gibbs, Simon A L ^b   Moore Jr , Francis D ^b   Hechtman, Herbert B ^a  

^a BRIGHAM AND WOMEN S HOSPITAL   (United States)

^b NONE

Author keywords

Acute Pancreatitis; cerulein; complement activation; inflammation; neutrophils; remote pulmonary injury; rodents; soluble complement receptor type 1

Indexed keywords

CERULETIDE; COMPLEMENT COMPONENT C3B RECEPTOR;

ACINAR CELL; ADULT RESPIRATORY DISTRESS SYNDROME; AMYLASE BLOOD LEVEL; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CELL DAMAGE; COMPLEMENT ACTIVATION; COMPLEMENT INHIBITION; CONTROLLED STUDY; DRUG INDUCED DISEASE; LUNG INJURY; NEUTROPHIL; NONHUMAN; PANCREATITIS; PRIORITY JOURNAL; RAT; RECEPTOR AFFINITY;

ACUTE DISEASE; ALANINE TRANSAMINASE; AMYLASES; ANALYSIS OF VARIANCE; ANIMALS; BIOLOGICAL MARKERS; CAERULEIN; COMPLEMENT ACTIVATION; COMPLEMENT INACTIVATOR PROTEINS; GASTROINTESTINAL AGENTS; LIVER; LUNG; MALE; ORGAN SIZE; PANCREATITIS; PEROXIDASE; RATS; RATS, SPRAGUE-DAWLEY; RECEPTORS, COMPLEMENT;

EID: 0029881377     PISSN: 01694197     EISSN: None     Source Type: Journal    
DOI: None     Document Type: Article

References (38)

1. Carey LC. Extra-abdominal manifestations of acute pancreatitis. Surgery 1979; 86: 337-342.
2. Ranson JHC. Etiological and prognostic factors in human acute pancreatitis: a review. Am J Gastroent 1982; 77: 663-683.
3. Horn JK, Ranson JHC, Goldstein IM, Weissler J, Curatola K, Taylor R, Perez D. Evidence of complement catabolism in experimental acute pancreatitis. Am J Pathol 1980; 101: 205-215.
4. Lankisch PG, Koop H, Kaboth U. Serum complement factors in human acute pancreatitis; Hepato-gastroenterol 1981; 28: 261-263.
5. Minta JO, Man D, Movat HZ. Kinetic studies on the fragmentation of the third component of complement (C3) by trypsin. J Immunol 1917; 118: 2192-2198.
6. Perez HD, Horn JK, Ong R, Goldstein IM. Complement (CS)-derived chemotactic activity in serum from patients with pancreatitis. J Lab Clin Med 1983; 101: 123-129.
7. Lassen A, Laurell AB, Ohlsson K. Correlation among complement activation, protease inhibitors, and clinical course in acute pancreatitis in man. Scand J Gastroent 1985; 20: 335-345.
8. Foulis AK, Murray WR, Galloway D, McCartney AC, Lang E, Veitch J, Whaley K. Endotoxaemia and complement activation in acute pancreatitis in man. Gut 1982; 23: 656-661.
9. Seelig R, Tschahargane EC, Seelig HP. The serum complement system-a mediator of acute pancreatitis. Virchows Arch Path A Anat and Histol 1975; 365: 193-199.
10. Tahamont MV, Barie PS, Blumenstock FA, Hussain MH, Malik AB. Increased lung vascular permeability after pancreatitis and trypsin infusion. Am J Pathol 1982; 109: 15-26.
11. Hohn DC, Meyers AJ, Gherini ST, Beckmann A, Markison RE, Churg AM. Production of acute pulmonary injury by leukocytes and activated complement. Surgery 1980; 88: 48-58.
12. Hammerschmidt DE, Weaver LJ, Hudson LD, Craddock PR, Jacob HS. Association of complement activation and elevation and elevated plasma-C5a with adult respiratory distress syndrome, pathophysiological relevance and possible prognostic value. Lancet 1980; 8175: 947-949.
13. Hill J, Lindsay TF, Ortiz F, Yeh CG, Hechtman HB, Moore FD Jr. Soluble complement receptor type 1 ameliorates the local and remote organ injury after intestinal ischemia-reperfusion in the rat. J Immunol 1992; 149: 1723-1728.
14. Lindsay TF, Hill J, Ortiz F, Rudolph A, Valeri CR, Hechtman HB, Moore FD Jr. Blockade of complement activation prevents local and pulmonary albumen leak after lower torso ischemia-reperfusion. Ann Surg 1992; 216: 677-683.
15. Whicher JT, Barnes MP, Brown A, Cooper MJ, Read R, Walters G, Williamson RCN. Complement activation and complement control proteins in acute pancreatitis. Gut 1982; 23: 944-950.
16. Kelly RH, Rao KN, Harvey VS, Lombardi B. Acute hemorrhagic pancreatic necrosis in mice: lack of a pathogenetic role for complement. Acta Hepato-Gastroenterol 1979; 26: 302309.
17. Kelly RH, Rao KN, Harvey S, Lombardi B. Acute hemorrhagic pancreatic necrosis in mice: alterations of serum complement. Digestion 1981,22: 1-7.
18. Steer ML. Workshop on Experimental pancreatitis. Dig Dis Sci 1985; 30: 575-581.
19. Orda R, Hadas N, Orda S, Wiznitzer T. Experimental acute pancreatitis. Arch Surg 1980; 115: 327-329.
20. Aho HJ, Koskensalo SML, Nevalainen TJ. Experimental pancreatitis in the rat. Scand J Gastroent 1980; 16:411-416.
21. Zhou W, Levine BA, Olson MS. Platelet-activating factor: a mediator of pancreatic inflammation during cerulin hyperstimulation. Am J Pathol 1993; 142: 1504-1512.
22. Lampel M, Kern HF. Acute interstitial pancreatitis in the rat induced by excessive doses of a pancreatic secretagogue. Virchows Arch Path A Anat and Histol 1977; 373: 97-117.
23. Guice KS, Oldham KT, Johnson KJ, Kunkel RG, Morganroth ML, Ward PA. Pancreatitis-induced acute lung injury. Ann Surg 1988; 208: 71-77.
24. Guice KS, Oldham KT, Caty MG, Johnson KJ, Ward PA. Neutrophil-dependent, oxygen-radical mediated lung injury associated with acute pancreatitis. Ann Surg 1989; 210: 740-747.
25. Fearon DT. Regulation of the amplification C3 convertase of human complement by an inhibitory protein isolated from human erythrocyte membrane. Proc Natl Acad Sci USA 1979; 76: 5867-5871.
26. Kloppel G. Pathology of acute pancreatitis, in Acute Pancreatitis: Diagnosis and Therapy, Bradley EL, ed., Raven, New York, 1994; pp. 35-46
27. Steer ML. Pathophysiology and pathogenesis of acute pancreatitis, in Acute Pancreatitis: Diagnosis and Therapy, Bradley EL, ed., Raven, New York, 1994; pp. 3-11.
28. Ranson JHC. Stratification of severity for acute pancreatitis, in Acute Pancreatitis: Diagnosis and Therapy, Bradley EL, ed., Raven, New York, 1994; pp. 13-20.
29. Toriumi Y, Samuel I, Wilcockson DP, Turkelson CM, Solomon TE, Joehl RJ. Increased circulating cholecystokinin in obstruction-induced acute pancreatitis I. Bile duct obstruction with and without pancreatic duct obstruction. J Surg Res 1993; 54: 132-135.
30. Freston JW, Cimetidine I. Development, pharmacology, and efficacy. Ann Intern Med 1982; 97: 573-580.
31. Saluja AK, Saluja M, Printz H, Zavertnik A, Sengupta A, Steer ML. Experimental pancreatitis is mediated by low-affinity cholecystokinin receptors that inhibit digestive enzyme secretion. Proc Natl Acad Sci USA 1989; 86: 89158-8971.
32. Nordback IH, Clemens JA, Cameron JL. The role of cholecystokinin in the pathogenesis of acute pancreatitis in the isolated pancreas preparation. Surgery 1991; 109: 301-306.
33. Weisman HF, Bartow T, Leppo MK, Marsh HC Jr, Carson GR, Concino MF, Boyle MP, Roux KH, Weisfeldt ML, Fearon DT. Soluble human complement receptor type 1: in vivo inhibitor of complement suppressing post-ischemic myocardial inflammation and necrosis. Science 1990; 249: 146-151.
34. Steer ML. How and where does acute pancreatitis begin? Arch Surg 1992; 127: 1350-1353.
35. Klar E, Mall G, Messmer K, Herfarth C, Rattner DW, Warshaw AL. Improvement of impaired pancreatic microcirculation by isovolemic hemodilution protects pancreatic morphology in acute biliary pancreatitis. Surg Gynecol Obstet 1993; 176: 144-150.
36. Zimmerli W, Reber AM, Dahinden CA. The role of formylpeptide receptors, C5a receptors, and cytosolic-free calcium in neutrophil priming. J Infect Dis 1990; 161: 242-249.
37. Kajita T, Huglia TE. C5a-induced neutropenia. A primary humoral mechanism for recruitment of neutrophils. Am J Pathol 1990; 137: 467-77.
38. Goldman G, Welbourn R, Klausner JM, Kobzik L, Valeri CR, Shepro D, Hechtman HB. Intravascular chemo-attractants inhibit diapedesis by selective receptor occupancy. Am J Physiol 1991; 260: H465-H472.